Dr. PAI 1.0 Officially Released: AIIA Fellow Project Expands New Frontiers in AI Applications

On March 14, 2026, the "Dr. PAI (Personalized AI Doctor) 1.0", the world's first intelligent hypertension management platform that continuous wearable blood pressure monitoring devices, AI doctor avatars, and large language models (LLMs), was officially launched in Beijing.

The platform was developed by a team led by Professor Zhang Yuanting, Fellow of the International Artificial Intelligence Industry Alliance (AIIA), Fellow of the International Academy of Medical and Biological Engineering, Fellow of the American Institute for Medical and Biological Engineering, founder of the Hong Kong Institute of Medical Engineering and chief scientist at Guangdong Medical University.

As an AIIA Fellow, Professor Zhang has long been dedicated to pioneering research at the intersection of medical engineering and intelligent health systems. The release of Dr. PAI demonstrates the practical deployment of AI technologies in specialized medical domains, and highlights the effectiveness of AIIA's academicians-led project support framework in facilitating real-world implementation.

Through the coordinated operation of continuous monitoring, intelligent consultation, risk warning, and personalized intervention recommendations, Dr. PAI establishes a closed-loop hypertension management system covering "Monitoring-Warning-Diagnosis-Intervention-Prediction." The system can be widely applied in family health management, community medical services, home-based elderly care, and chronic disease management, promoting the transformation of chronic disease management from passive treatment to active health maintenance.

Key Features Include:

· Continuous, Non-intrusive Data Acquisition:

Integration with wearable cuffless devices such as smart blood pressure rings enables continuous measurement and intelligent analysis of multi-parameter health data, including blood pressure trends, ECG, and sleep patterns.

· Comprehensive Medical Knowledge Support:

The system incorporates structured medical knowledge resources such as "3,000 Questions on Hypertension Screening and Prevention", covering screening, diagnosis, medication, emergency identification, and lifestyle interventions. AI-powered Q&A provides accurate and accessible health information.

· Clinical Navigation and Efficiency Enhancement:

Through structured question guidance, the system helps patients better understand clinical processes, identify key concerns in advance, and improve consultation efficiency and communication quality.

· AI Doctor Avatar with Clinical Reasoning:

By embedding clinical expertise—including diagnostic logic, risk identification principles, and decision pathways—the system enables AI responses aligned with real clinical thinking, providing standardized and actionable health management recommendations.

China currently has over 300 million patients with cardiovascular diseases. Hypertension, often referred to as a "silent killer," continues to face challenges such as insufficient post-discharge management, low patient adherence, and limited access to professional guidance.

Many clinical experts noted that Dr. PAI effectively addresses the gap in out-of-hospital management. By extending medical expertise into daily life, the platform supports early detection, prevention, diagnosis, intervention, and rehabilitation of major diseases such as hypertension, providing strong technological support for primary-level chronic disease management.

According to the development team, Dr. PAI will expand beyond hypertension to cover additional chronic conditions, including diabetes, cardiovascular diseases, and sleep disorders, further promoting the transition from reactive healthcare to proactive prevention.

The Dr. PAI platform represents a significant outcome of AIIA Fellows integrating AI technologies with real-world public health applications and serves as a benchmark case within the Alliance's academicians-led project framework.

With leading scientists and academicians as the core drivers of innovation and industrialization, AIIA provides comprehensive, lifecycle-oriented support for innovation projects led by top-tier experts. AIIA focuses on deep collaboration across academia, industry, research, and application, including:

· Connecting global leading research institutions and universities to strengthen technological foundations;

· Bridging industry leaders with real-world application scenarios to accelerate commercialization;

· Integrating key resources such as capital, policy, and talent to overcome implementation barriers;

· Establishing platforms for industry collaboration and standard development to support sustainable and high-quality growth.

Leveraging the academic leadership and innovation capacity of distinguished experts, AIIA continues to promote the transition of AI technologies from fundamental research to vertical applications across critical sectors, including healthcare, public services, industrial upgrading, and social governance.

Looking ahead, AIIA will continue to enhance its academicians-led project support mechanism, further strengthening capabilities in resource integration, ecosystem collaboration, and technology commercialization.

By leveraging top-tier talent, advancing technological innovation, and focusing on real-world deployment, AIIA aims to accelerate the large-scale application of AI innovations and promote the deep integration of artificial intelligence across industries, enabling broader societal impact.